Article
Intestinal-specific PPARgamma deficiency enhances tumorigenesis in ApcMin/+ mice.
International journal of cancer - 15 Nov 2006
McAlpine Christen A, Barak Yaacov, Matise Ilze, Cormier Robert T
Abstract excerpt
Multiple investigations of the effects of peroxisome proliferator-activated receptor gamma (PPARgamma) ligands on colon cancer have produced contradictory results. While some studies demonstrated increased numbers of colonic polyps in Apc(Min/+) mice treated with various thiazolidinedione (TZD) PPARgamma ligands, others reported amelioration of tumor multiplicity and progression in both Apc(Min/+) mice and in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
